Physician profile
Antonio Festa
NPI 1710106315
$680.57
in general payments reported to CMS, 2019-2025
7 companies · $147 in 2025
The $147 reported for 2025 was more than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.60 · 2020: $217 · 2021: $74.25 · 2022: $26.56 · 2023: $86.45 · 2024: $83.35 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $303 · Education: $13.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $303.48 |
| Education | $13.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $296.54 | 2019-2025 | Invisalign |
| Orapharma, A Division of Bausch Health US, LLC | $170.37 | 2019-2024 | Arestin, Ossix Plus |
| Envista Holdings Corporation | $81.89 | 2024-2025 | Zirconia Abutment Preparation Kit, Maxcem Elite |
| Dentsply Sirona INC | $43.94 | 2023-2025 | Orthophos E, Suresmile |
| Gc America INC. | $37.93 | 2020-2023 | G-Aenial |
| Colgate Oral Pharmaceuticals, INC. | $26.05 | 2021-2022 | |
| Voco America INC. | $23.85 | 2024 | Admira Fusion X-Tra, Admira Fusion X-Base |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonio Festa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.